Their metabolic health markers, such as blood sugar and cholesterol, also returned to levels similar to those before treatment.(3) Another drawback to taking GLP-1 medications is that while they promote weight loss, recently published research shows that approximately 15% to 60% of the loss comes from lean mass.(5, 6) This is very concerning, because preserving muscle mass is crucial for maintaining metabolic rate, overall health, and functionality as we age.(7) The Potential Solution: A Ketogenic Lifestyle A paper by researchers at Virta Health, published in February 2024, suggests that a ketogenic diet may help people maintain their weight loss after transitioning off GLP-1 medications.(8) The study compared two groups of type 2 diabetes patients following a ketogenic diet: one group continued GLP-1 therapy, and the other group stopped the medication
Like the Wegovy injection, its approved for weight management in adults and children aged 12 and up who live with obesity and weigh more than 132 pounds, and for adults with overweight and a related condition, such as hypertension or high cholesterol
The reason for the slow climb is simple: jumping straight to a high dose tends to cause more nausea and stomach upset
GLP-1 therapy works by supporting your biology, making results more sustainable with ongoing guidance
Patience during reconstitution prevents foaming and denaturation
Patients typically experience: Less hunger More satisfaction after smaller meals Reduced cravings Steadier energy during the day Better portion control Natural lifestyle improvements This is why Wegovy for weight loss has become one of the leading treatments worldwide
